Fig. 4

Validation of the risk score model in the validation set. A. Patients were divided into high- and low-risk groups according to the median of the risk score; B. Heatmap showed the expressions of prognostic gene signature in high- and low-risk groups. C K-M analysis of high- and low-risk groups; D-F ROC curves of 1-, 3- and 5-year survival prediction of cervical carcinoma patients